Your browser doesn't support javascript.
loading
Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3.
Joshi, Ricky; Shvartsman, Maya; Morán, Erica; Lois, Sergi; Aranda, Jessica; Barqué, Anna; de la Cruz, Xavier; Bruguera, Miquel; Vagace, José Manuel; Gervasini, Guillermo; Sanz, Cristina; Sánchez, Mayka.
Afiliação
  • Joshi R; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain.
  • Shvartsman M; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain.
  • Morán E; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain ; Diagnostics in Iron Metabolism Service (D·IRON) and Iron Metabolism: Regulation and Diseases group, Josep Carreras Leukem
  • Lois S; Vall d'Hebron Research Institute (VHIR) Barcelona, Spain.
  • Aranda J; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain ; Diagnostics in Iron Metabolism Service (D·IRON) and Iron Metabolism: Regulation and Diseases group, Josep Carreras Leukem
  • Barqué A; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain ; Diagnostics in Iron Metabolism Service (D·IRON) and Iron Metabolism: Regulation and Diseases group, Josep Carreras Leukem
  • de la Cruz X; Vall d'Hebron Research Institute (VHIR) Barcelona, Spain ; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona, Catalonia, Spain.
  • Bruguera M; Service of Hepatology, Clinic Hospital of Barcelona Barcelona, Spain.
  • Vagace JM; Service of Haematology, Hospital Materno-Infantil de Badajoz Badajoz, Spain.
  • Gervasini G; Department of Surgical & Medical Therapeutics, University of Extremadura Badajoz, Spain.
  • Sanz C; Service of Haematology and Hemotherapy, Clinic Hospital of Barcelona Barcelona, Spain.
  • Sánchez M; Cancer and Iron Group and Advanced Genetic Diagnostic Unit of Rare Iron Disorders (UDGAEMH), Institut of Predictive and Personalized Medicine of Cancer (IMPPC) Barcelona, Spain ; Diagnostics in Iron Metabolism Service (D·IRON) and Iron Metabolism: Regulation and Diseases group, Josep Carreras Leukem
Mol Genet Genomic Med ; 3(3): 221-32, 2015 May.
Article em En | MEDLINE | ID: mdl-26029709
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha